Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacteol Forte as Adjunctive Therapy for ADHD in Children and Adolescents
NCT04167995Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lactobacillus LB in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Ain Shams University. Primary endpoints: Conner's Parent Rating Scales-Revised at 3 months and Child Behavior Checklist at 3 months. Started Jun 2020; status: completed.
02
Drugs
Lactobacillus LB
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04167995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167995.